Imlunestrant joins elacestrant (Orserdu) as the only FDA-approved oral therapies for ESR1 -mutant breast cancer. In contrast ...

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo ...

The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...

Eli Lilly secures EU approval for Alzheimer's drug Kisunla and gains FDA nod to breast cancer therapy Inluriyo.

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

Berlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

Often administered to cancer patients alongside chemotherapy in the form of an IV, Leucovorin, is now being explored as a ...

Eli Lilly (LLY) stock is in focus as the company posts detailed data from a late-stage trial for its obesity pill ...

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus” or the "Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer ...

It's best to avoid certain types of food and drink before bedtime if you want to be sure of a good night's sleep. Here's what ...

A team from Sun Yat-sen University Sun Yat-sen Memorial Hospital has identified a novel mechanism underlying platinum resistance in triple-negative breast cancer (TNBC): the circular RNA circSCAP ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...